Cancer screening startup raises $22M
ROYAL OAK—OncoCell MDx Inc., a startup incubated at Harvard University to develop sophisticated cancer diagnosis from a simple blood sample, announced that it has raised $22.2 million in a Preferred …
Pharma startup names veteran exec to board
ROYAL OAK—OncoCell MDx, a company developing new, noninvasive molecular diagnostic assays for cancer and other diseases, announced that Marc Stapley has joined the company’s board of directors. Stapley is currently …
Biotech firm names chief medical officer
ROYAL OAK — OncoCell MDx, an immunogenomics company developing new, noninvasive molecular diagnostic assays, announced that Kirk Wojno, M.D., has joined the company’s leadership team as its chief medical officer. …